Various HLA typing reagents
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N90019D00017
- Awardee
-
One Lambda, Inc. UEI YXYJG67KTLL7
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Human Leukocyte Antigen (HLA) Kits for Transfusion Medicine Pre-Solicitation · 19007888 · Posted Apr 17, 2019
- Last date to order 100% complete
- IDV ceiling
- $586,949.71
- Maximum order
- $10,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
One Lambda, Inc., a subsidiary of Thermo Electron Corporation specializing in immunogenetic and transplant diagnostic testing solutions, was awarded a single-award Indefinite Delivery Contract by the National Institutes of Health (NIH) Clinical Center on May 23, 2019, with a contract ceiling of $586,949.71 and an ultimate completion date of June 9, 2020. The contract procures various Human Leukocyte Antigen (HLA) typing reagents and related laboratory diagnostic products essential for transplant compatibility testing and immunogenetic research activities. The pre-solicitation opportunity was posted on April 17, 2019, with a due date of April 29, 2019, and was awarded without set-aside designation, indicating open competition. As a civilian federal agency, the NIH Clinical Center selected One Lambda as the sole awardee based on the company's established expertise and capabilities in providing specialized HLA typing products and laboratory supplies to federal healthcare and research institutions.
The contract structure as an Indefinite Delivery Vehicle enables the NIH Clinical Center to issue task orders for needed HLA typing reagents and diagnostic supplies on an as-needed basis within the established ceiling value. One Lambda's HLA typing reagents support critical medical research and clinical transplant protocols conducted at the NIH Clinical Center, contributing to immunogenetic testing capabilities necessary for organ compatibility assessments and related biomedical research initiatives. The award notation regarding administrative de-obligation of unexpended and expiring fiscal year 2021 funding indicates that portions of the contract funding were subject to fiscal year fund availability provisions under 31 U.S.C. Section 1552(a), reflecting standard federal budget management practices for obligated but unspent appropriations prior to the September 30, 2026 period of availability closing.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,208 | |
| Funding Only Action | -$427 | |
| Funding Only Action | $65,000 | |
| Original award | $523,584 |
Quick answers
Who was awarded contract 75N90019D00017?
75N90019D00017 was awarded to One Lambda, Inc. by NIH Clinical Center (National Institutes of Health) on May 23, 2019.
How much is contract 75N90019D00017 worth?
75N90019D00017's own ceiling is $586,950. A single order can be worth up to $10,000.
Who can order from contract 75N90019D00017?
75N90019D00017 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N90019D00017 competed?
The extent of competition for 75N90019D00017 was not competed under sap. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV